MARKET

FBIOP

FBIOP

Fortress Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.29
-0.06
-0.33%
Closed 16:00 05/22 EDT
OPEN
18.49
PREV CLOSE
18.35
HIGH
18.50
LOW
18.24
VOLUME
23.75K
TURNOVER
--
52 WEEK HIGH
21.95
52 WEEK LOW
12.00
MARKET CAP
37.31M
P/E (TTM)
-19.8223
1D
5D
1M
3M
1Y
5Y

FBIOP News

More
Earnings dominate premarket gainers
Seeking Alpha - Article · 05/08 13:15
Fortress Bio closes license deal with Columbia U. for cancer candidates
Seeking Alpha - Article · 05/08 11:44
Fortress Biotech Announces Up to $5 Million Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase Program
GlobeNewswire · 03/23 14:20
Fortress Biotech Announces Closing of Series A Preferred Stock Offering and Full Exercise of Over-Allotment Option
GlobeNewswire · 02/24 13:00
Checkpoint Therapeutics: Beat The System
Seeking Alpha - Article · 02/21 20:59
Fortress Biotech (FBIO) Investor Presentation - Slideshow
Seeking Alpha - Article · 02/19 18:58
Goldman likes Intuitive Surgical in premarket analyst action
Seeking Alpha - Article · 02/13 13:30
CYBR, BBBY among premarket losers
Seeking Alpha - Article · 02/12 14:17

Industry

Pharmaceuticals
-0.29%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Symbol
Price
%Change

About FBIOP

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
More

Webull offers kinds of Fortress Biotech Inc stock information, including NASDAQ:FBIOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIOP stock news, and many more online research tools to help you make informed decisions.